Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
R01AG070915), the National Institute of Neurological Disorders and Stroke (R01NS100782), the National Cancer Institute (R01CA255840), the Oklahoma Shared Clinical and Translational Resources (U54GM104938) with an Institutional Development Award (IDeA) from NIGMS, the Presbyterian Health Foundation, the Reynolds Foundation, the Oklahoma Nathan Shock Center (P30AG050911), and the Cellular and Molecular GeroScience CoBRE (P20GM125528), the NCI Cancer Center Support Grant (P30 CA225520) and the Oklahoma Tobacco Settlement Endowment Trust
doi: 10.1039/d2fo02369e 58 ChoiG.BessmanN
The combination approach of targeting two separate pathways produces results competitive with even the most effective single-agent therapies currently available
A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials
Because buying research chemicals involves navigating complex specifications, this comprehensive product guide covers the science, quality metrics, and evaluation steps required for safe procurement
WuXZhangLMiaoYYangJWangXWangCCet alHomocysteine causes vascular endothelial dysfunction by disrupting endoplasmic reticulum redox homeostasis
US$ 21.55
US$ 22.18
US$ 27.53
US$ 25.22
US$ 28.88
US$ 23.39
